In clinical and forensic toxicology, general unknown screening is used to detect and identify exogenous compounds. In this study, we aimed to develop a comprehensive general unknown screening method based on liquid chromatography coupled with a hybrid triple-quadrupole linear ion trap mass spectrometer. Methods: After solid-phase extraction, separation was performed using gradient reversed-phase chromatography. The mass spectrometer was operated in the Information-Dependent Acquisition mode, switching between a survey scan acquired in the Enhanced Mass Spectrometry mode with dynamic subtraction of background noise and a dependent scan obtained in the Enhanced Product Ion scan mode. The complete cycle time lasted 1.36 s. A library of 1000 Enhanced Product Ion-tandem mass spectrometry spectra in positive mode and 250 in negative mode, generated using 3 alternated collision tensions during each scan, was created by injecting pure solutions of drugs and toxic compounds. Results: Comparison with high-performance liquid chromatography-diode array detection and gas chromatography-mass spectrometry for the analysis of 36 clinical samples showed that linear ion trap tandem mass spectrometry could identify most of the compounds (94% of the total). Some compounds were only detected by 1 of the other 2 techniques. Specific clinical cases highlighted the advantages and limitations of the method.
has been a useful complement to immunoassays, HPLCdiode array detection (DAD) and gas chromatography (GC)-MS for the general unknown screening of drugs and toxic compounds (1) (2) (3) (4) . LC-MS is not affected by the limitation of GC-MS to volatile compounds. However, for single MS, the fragments obtained by in-source collisioninduced dissociation at various orifice voltages (5 ) are less informative and reliable than the spectra obtained with electron ionization in GC-MS. Recent methods have used Data-or Information-Dependent Acquisition (IDA), an artificial intelligence program (6 ) aimed at improving compound identification with tandem mass spectrometry. IDA is able to detect the most abundant ions in each scan obtained in the single-stage mass spectrometry mode (survey scan mode), and automatically and immediately switch the instrument to the product-ion scan mode (dependent scan mode), where these ions are selectively transmitted by the first quadrupole to the collision cell, and the resulting fragments are analyzed in the 3rd quadrupole. Subsequently, the instrument is switched back to the survey scan. Using a closed ion trap instrument Fitzgerald et al. (7 ) used this procedure to identify 17 basic drugs. Decaestecker et al. used different IDA approaches with a hybrid quadrupole time-of-flight instrument operated in the positive mode (6, 8 ) . Mü ller et al. (9 ) recently developed a multitarget screening of 301 compounds with multiple reaction monitoring as the survey mode and enhanced product ion (EPI) scan mode as the dependent mode on a hybrid triple-quadrupole linear ion trap system. IDA has also been evaluated for the general unknown screening (GUS) of drugs and toxicants with the same instrument model (10 ) , whose 2nd MS stage is equipped with entrance and exit lenses, giving it the properties of an ion trap (see Fig. 1 in the Data Supplement that accompanies the online version of this article at http://www.clinchem.org/content/vol52/ issue9) (11 ) . The enhanced MS (EMS) full-scan mode, where all the molecular or pseudomolecular ions produced in the source in the specified m/z range are trapped in the linear ion trap before being detected, was used as the survey mode. The EPI scan mode, in which the fragment ions produced in the collision cell are trapped in the linear ion trap before being detected or refragmented, was used as the dependent mode. A reconstituted spectrum was generated by adding up the EPI mass spectra obtained separately at 3 different collision energies (10 ) . Using the same instrument, EPI spectra were compared with classic daughter-ion spectra, robustness of EPI spectra were evaluated, and IDA conditions were determined to allow identification of a wide range of compounds (12 ) .
In this study, we present a method aimed at development of a comprehensive and optimized GUS procedure based on linear ion trap MS/MS, using new computer program capabilities and at application of this procedure to clinical and forensic samples, to evaluate its performance.
Materials and Methods standards and reagents
Organic solvents and reagents were analytical grade. Were obtained acetonitrile and methanol from Carlo Erba, dichloromethane and isopropanol from Prolabo, and formic acid and ammonium formate from Sigma. Deionized water was used. The internal standard Glafenine (IS) was purchased from Sigma. Oasis MCX and HLB cartridges were purchased from Waters. We prepared stock solutions of standard compounds at 1 g/L in methanol for most compounds, with acetonitrile or water used for certain molecules because of solubility issues, and the solutions were kept at 4°C or Ϫ20°C (e.g., for benzodiazepines), depending on their stability.
liquid chromatography
The chromatographic system consisted of a Perkin-Elmer Series 200LC high-pressure gradient pumping system and a Rheodyne Model 7725 injection valve equipped with a 5-L internal loop. A Waters XTerra MS C18, 3.5 m (100 ϫ 2.1 mm) column, maintained at 25°C, was used with a linear gradient of mobile phase A (pH 3.0, 0. Positive ionization was performed with the following settings: ion spray voltage, 5000 V; curtain gas, 20; Ion Source Gas 1; and GS 2 at 15 and 35 units, respectively; declustering potential, 50 V; and temperature 350°C. In the negative mode, the ion spray voltage was set to Ϫ4500 V, declustering potential at Ϫ50 V, and source temperature at 350°C.
enhanced ms conditions
In the survey scan mode, the dynamic fill-time option was chosen, and m/z ratios were scanned from 100 to 1100 amu at a rate of 4000 amu/s. The EMS total scan time was 0.49 s. A new feature of the Analyst 1.4 Software, called Dynamic Background Subtraction (DBS) (13 ) was also used.
information-dependent acquisition conditions
The 3 most intense ions in each background-subtracted EMS spectrum were selected as parent ions without applying any intensity threshold; each ion could be selected for a maximum of 4 occurrences; and the ions previously selected for 4 occurrences were excluded for 15 s.
enhanced product ion conditions
Collision energy was set at 40 V and Ϫ40 V and collision energy spread at 25 V and Ϫ25 V, in the positive and negative modes, respectively. Consequently, fragments generated at ϳ15, ϳ40, and ϳ65 V were accumulated in the linear ion trap and analyzed altogether by scanning the ϳ50 -1100 m/z range at a rate of 4000 amu/s, leading to a scan time of 0.87 s, so that a complete cycle (EMS, IDA, and EPI) lasted 1.36 s. The dynamic fill-time option was also used in the EPI mode, and the source variables were kept unchanged.
libraries of enhanced product ion ms/ms spectra
A library of EPI MS/MS spectra was created by injecting mixtures of freshly prepared stock solutions of compounds (ϳ10 compounds per solution including the IS glafenine) at 10 g/mL in acetonitrile:pH 3.0, 2 mmol/L ammonium formate (30:70, by volume), in both polarities successively. After checking the fragments obtained against the LC-MS/MS literature or using Mass Frontier 4.0 (HighChem Ltd.), the pertinent EPI spectra were entered in the library. The relative retention time was added manually to each library entry, together with the compound chemical structure and CAS number (Merck Index, http://chem.sis.nlm.nih.gov/chemidplus/ or drawn using ChemSketch 7.0 (Advanced Chemistry Development)).
library searching
We performed the library search with the Library Search tool in the Analyst 1.4 Software. The search results were sorted by 3 criteria: (i) purity, measured as the unmatched peaks between the unknown and known spectra; (ii) fit, measured by how well a library spectrum matches the unknown spectrum; and (iii) reverse fit, which measures how well the unknown spectrum matches a library spectrum. All these criteria range from 0% to 100%.
automatic data analysis and reporting
A specific program called "AutoSearch" was developed for this study by Applied Biosystems/MDS Sciex. This program allows an automatic detection of chromatographic peaks in the EMS survey scan and a comparison of the underlying EPI spectra with those in the library. Excel reports list peaks intensity, the name(s) of the identified compound(s), identification criteria (purity, fit, and reverse fit), relative retention time, and peak height and area on the EMS survey trace. The similarity of the EPI spectra obtained with library entries is evaluated primarily with the purity factor. Search results with purity higher than a predefined value (here 60%) appear in bold characters, and the 1 to 3 best hits for each unknown spectrum can be visualized (Fig. 2 in the online Data Supplement). The relative retention times were compared with those in the library with an acceptability threshold of ϳ5%.
Only peaks above a fixed intensity threshold and a signal-to-noise ratio Ͼ3 were tagged for automatic MS/MS library searching.
sample preparation To 1 mL serum, plasma, urine, or gastric content, we added 100 L of a 10 g/mL aqueous solution of glafenine (IS). After vortex-mixing, we loaded the mixture on an Oasis HLB cartridge, previously conditioned with 2 mL methanol and 2 mL water. After rinsing the cartridge with 3 mL water and 3 mL of water mixed with methanol at a ratio of 90:10, by volume, elution was performed with 3 mL dichloromethane:isopropanol (75:25, by volume), containing 2% formic acid. Extracts were evaporated to dry and reconstituted in 100 L acetonitrile: pH 3.0, 2 mmol/L ammonium formate (30:70, by volume). Whole blood samples were precipitated with a saturated mixture of zinc sulfate:methanol (70:30, by volume), centrifuged at 3400g (3000 rpm) for 5 min and the supernatant diluted 1/3 with water before extraction.
ion suppression and extraction recovery We checked ion suppression by infusing at 50 L/min into the ion source a mixture of 20 compounds at 100 ng/mL in acetonitrile: pH 3.0, 2 mmol/L ammonium formate (30:70, by volume), while injecting into the chromatographic system extracts of blank serum, urine, or whole blood in parallel, the 2 flows being merged by means of a peek tee at source entrance.
Extraction recovery in whole blood and plasma was determined for 54 compounds by comparing the peak areas of extracted compounds (3 replicates of blank matrix added at 100 ng/mL) with those of extracts of the blank matrix reconstituted with a 1 mg/L solution of the same compounds in the above mentioned solvent.
We set up another acquisition method to achieve these tests by introducing the following modifications: (i) the linear ion trap (LIT) fill-time was fixed at 100 ms in the EMS mode; (ii) no exclusion of previously selected ions was applied; and (iii) no background subtraction was applied.
Results and Discussion
The different steps of the acquisition process are presented in Fig. 1 , which corresponds to the injection of a mixture of 10 antipsychotics at 100 ng/mL in the positive ion mode. The arrow in Fig. 1A (total ion current of the survey scan mode) shows the retention time considered in this example. Fig. 1B presents the underlying survey MS, and Fig. 1C the extracted ion chromatogram at m/z 370. Fig. 1D presents the rich and clean EPI spectrum of amisulpride resulting from the fragmentation of m/z 370 in the collision cell at 3 alternated fragmentation voltages. The protonated molecules were always present in the EMS survey scan, while a fragment of higher intensity than the pseudo-molecular ion was found in only one of the 11 above-mentioned compounds. Because the concentrations of compounds in biological samples can vary, the dynamic fill-time option was chosen in the survey scan mode to automatically adjust the LIT fill time as a function of ion density in the ion trap and to decrease the risks of missing co-eluting or low-intensity peaks. By use of DBS, the best results in terms of detection of compounds of interest were obtained with 3-point SavitskyGolay smoothing of mass spectra and subtraction of the mean of the 2 spectra (defined as background noise)
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preceding the survey scan. DBS resulted in the IDA selection of ions with increasing intensity only, because the subtraction process canceled the m/z ratios with stable or decreasing intensity, enhancing the signal-to-noise ratio and facilitating the selection of pertinent parent ions. Because of this real-time background subtraction, the IDA intensity threshold could be set at 0. To decrease the risks of false-negative results in case of co-elution, the 3 most intense ions were selected for a maximum of 4 occurrences, and then they were excluded for 15 s. As shown in Fig. 2 , cyamemazine, trimeprazine, and methotrimeprazine had almost the same retention time but, using these IDA settings, each could be unambiguously identified at 10 ng/mL. As previously described (12 ), each EPI spectrum was composed of fragments generated from the same parent ion at 3 different collision energies within a single scan, resulting from the accumulating property of the LIT and the new collision energy spread feature of the software (see Fig. 3 in the online Data Supplement).
The current library is comprised of ϳ1000 EPI spectra in the positive mode and 250 EPI spectra in the negative mode. The EPI spectra contain at least 4 fragments with a relative abundance Ͼ10%, including those of the molecular or pseudomolecular ion. The robustness of the EPI spectra obtained in the positive mode was studied during 3 periods of 5 days over a period of 6 months, with 5 injections per day of a 10-g/mL mixture of 5 compounds (amisulpride, clozapine, metoclopramide, nordazepam, and tiapride, chosen with respect to their fragmentation properties; see Table 1 in the Data Supplement that accompanies the online version of this article at http:// www.clinchem.org/vol52/issue9). The interassay CV of the relative intensity (calculated using 1-way ANOVA with occasion as grouping factor, following Krouwer and Rabinowitz (18 ) , was always Ͻ22% and intraassay CV% Ͻ15%.
During this period, the QTRAP instrument was regularly used for analyzing samples of various biological matrices, so preventative cleaning of the curtain plate, orifice, and cone was arbitrarily performed once a week. The source also had to be cleaned when pollution or dirtiness were detected by multiple reaction monitoring techniques, because sensitivity and signal-to-noise ratios are difficult to assess with the present procedure because of the autoadaptive LIT fill time. The chromatographic column used was stable for Ͼ1300 injections.
As previously reported (4 ), solid-phase extraction with a mixed-mode phase (Oasis MCX) was a good compro- mise between nonselectiveness and high yield. However, the analysis of a Seronorm Pharmaca Level 1 internal quality control by this extraction procedure and the present GUS method showed that some compounds were not detected, in particular nortriptyline and desipramine, although their presence had been confirmed by a quantitative LC-MS/MS technique in the multiple reaction monitoring mode developed for this purpose (Table 1) . To improve the extraction conditions, enriched and internal quality-controlled samples were extracted in parallel with Oasis MCX or HLB cartridges. Although some peaks showed higher intensity with the MCX, some compounds were only detected and identified at therapeutic concentrations with the HLB extraction (Table 1) . Moreover, despite the lower recovery, antidepressants present in 12 serum samples sent to our laboratory for therapeutic drug monitoring by LC-MS/MS (17 ) were detected with a purity Ն85% using the present GUS technique (see Table  2 in the online Data Supplement).
No ion suppression was observed at the retention time of the 20 compounds studied (see Fig. 4 in the online Data Supplement). Ion suppression cannot universally be appraised, but the 20 compounds used for this experiment present a wide range of retention times (5.5 to 18.5 min) and polarity.
The tests for ion suppression and extraction recovery were performed at different IDA settings from those of the GUS procedure, because the combined effects of automatic exclusion after selection, automatic background subtraction, and dynamic (i.e., variable) trap fill time did not allow computation of the peak area of a selected ion on the EMS survey trace. The chromatographic peaks would have been interrupted in their ascending part, 2 successive acquisition time periods would not necessarily have corresponded to the same trap fill time, and the horizontal signal expected with the continuous infusion of pure standards (in the absence of any ion suppression) would have been erratic.
The extraction recovery results for 54 compounds, presented in Table 2 , show higher yields in plasma than in whole blood. However, all values were Ͼ40% (and in plasma most of them were Ͼ90%). Decaestecker et al. compared the extraction yields obtained for 18 basic and neutral compounds with 7 nonpolar, 3 mixed-mode, and 2 polymeric solid-phase extraction sorbents (15 ) . They found that the Isolute C 8 and OASIS MCX (mixed-mode) phases had the highest clean-up potential, and that the former gave the best extraction yields. In a second step, they optimized the extraction procedure on the C 8 sorbent, which led to a higher recovery (75% to 100%) for all drugs except for benzoylecgonine and morphine, whose recovery decreased by ϳ40% (16 ) . The present extraction procedure appears to be at least as efficient for a larger number of drugs tested. This combination of improved extraction conditions and GUS technique improved the detection and identification of compounds compared with our previous results (4, 5, 12 ) . Although it has been shown herein that some antidepressants and antipsychotics could be identified at concentrations as low as at 10 ng/mL, the detection limits of drugs from various therapeutic classes warrant further studies. Because only peaks above a fixed intensity threshold and a signal-to-noise ratio Ͼ3 were tagged for automatic MS/MS library searching, further manual analysis and inspection of each EPI trace by an experienced operator is mandatory, because some low-intensity or coeluting peaks might not be picked up by the automatic data processing program. Indeed, IDA and EPI are applied to each scan without intensity or signal-to-noise ratio conditions.
The present GUS technique was tested for different types of matrices by comparing the present LC-MS/MS with GC-MS and HPLC-DAD (4 ) for the analysis of 36 actual specimens (3 gastric content, 6 serum, 8 whole blood, and 19 urine samples). Of the 130 positive results (89 different compounds), 94% were obtained using the present GUS technique, of which 19% were only identified by the present GUS technique (Fig. 3) . Moreover, each of the compounds identified by LC-MS/MS was the first hit from the search process with a purity factor always Ͼ75%. By comparison, GC-MS identified 64% of the compounds (1.5% not found by the other techniques) and HPLC-DAD identified 55% (1.5% unique findings). Some compounds, particularly antidepressants and antipsychotics, could only be identified using the present GUS technique because of high extraction recovery and high selectivity in the IDA mode with DBS. A few compounds, which are usually detectable by GC-MS and/or HPLC-DAD, were not detected in some specimens because of co-elution with other compounds with larger peaks. Conversely, the absence of detection of2 benzodiazepines by LC-MS/MS resulted from a poor extraction recovery of Ͻ50% for these compounds in whole blood.
In 1 case of acute intoxication, numerous compounds belonging to various therapeutic classes were detected in serum, urine and gastric content. Only LC-MS/MS was able to identify venlafaxine in serum and domperidone in urine, while nordiazepam was only detected by GC-MS (after manual search). All the other compounds were also identified by LC-MS/MS, while the other2 techniques were unable to detect the urine metabolites of 6 out of the 9 parent compounds ( Table 3 in The present GUS technique is efficient for a large range of compounds and complementary to the other classical screening techniques. Identification of metabolites is possible in certain cases because of their spectral similarities to their parent compound, even when the latter is not found. However, confirmation of the nature of putative metabolites is systematically performed by (i) injecting these metabolites as pure compounds, if available; (ii) comparison with MS/MS spectra in the literature; or (iii) performing in vitro metabolism experiments with a pool of human liver microsomes and analyzing the incubation supernatants with the present technique (e.g., zolpidem metabolite see Fig. 7 in the online Data Supplement). This allows continuous enrichment of our library.
Diode-array detection was also used upstream to MS/ MS, but the computer program used was unable to process the UV spectra. Hopefully, future software developments will allow this so that the number of screening techniques running in parallel can theoretically be decreased. Clinical Chemistry 52, No. 9, 2006 
